MX2007005054A - Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax. - Google Patents
Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax.Info
- Publication number
- MX2007005054A MX2007005054A MX2007005054A MX2007005054A MX2007005054A MX 2007005054 A MX2007005054 A MX 2007005054A MX 2007005054 A MX2007005054 A MX 2007005054A MX 2007005054 A MX2007005054 A MX 2007005054A MX 2007005054 A MX2007005054 A MX 2007005054A
- Authority
- MX
- Mexico
- Prior art keywords
- vwfa
- ant
- proteins
- domain containing
- containing proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
Abstract
Esta invencion se refiere a una nueva proteina, denominada INSP201, identificada en la presente como una proteina que contiene el dominio vWFA y/o ANT_IG, preferiblemente como una proteina tipo ATR y al uso de esta proteina y a las secuencias de acido nucleico provenientes del gen de codificacion, en el diagnostico, prevencion y tratamiento de enfermedades.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0423974.5A GB0423974D0 (en) | 2004-10-28 | 2004-10-28 | Proteins |
PCT/GB2005/004191 WO2006046072A2 (en) | 2004-10-28 | 2005-10-28 | VWFA AND/OR ANT_IG DOMAIN CONTAINING PROTEINS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007005054A true MX2007005054A (es) | 2007-06-19 |
Family
ID=33515721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007005054A MX2007005054A (es) | 2004-10-28 | 2005-10-28 | Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax. |
Country Status (15)
Country | Link |
---|---|
US (1) | US8222371B2 (es) |
EP (1) | EP1812462A2 (es) |
JP (1) | JP2008517616A (es) |
KR (1) | KR20070085342A (es) |
CN (1) | CN101115767B (es) |
AU (1) | AU2005298445B2 (es) |
BR (1) | BRPI0517362A (es) |
CA (1) | CA2584732A1 (es) |
EA (1) | EA013251B1 (es) |
GB (1) | GB0423974D0 (es) |
IL (1) | IL182749A (es) |
MX (1) | MX2007005054A (es) |
NO (1) | NO20072076L (es) |
UA (1) | UA93661C2 (es) |
WO (1) | WO2006046072A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1290027B1 (en) | 2000-04-28 | 2009-09-09 | Planet Biotechnology, Inc. | Immunoadhesin for the prevention of rhinovirus infection |
CN101277970B (zh) * | 2005-08-02 | 2014-05-07 | 行星生物技术有限公司 | 改良的嵌合毒素受体蛋白和用于治疗和预防炭疽的嵌合毒素受体蛋白 |
US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
US8680019B2 (en) * | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
AU2008287426B2 (en) * | 2007-08-10 | 2014-06-26 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
PT2499165T (pt) * | 2009-11-13 | 2016-10-28 | Grifols Therapeutics Inc | Preparações que contêm o fator de von willebrand (vwf), e métodos, kits e utilizações relacionadas com as mesmas |
WO2013152351A2 (en) * | 2012-04-06 | 2013-10-10 | The Trustees Of Columbia University In The City Of New York | Fusion polypeptides and methods of use thereof |
RU2013131870A (ru) * | 2013-07-11 | 2015-01-20 | Павлов Владимир Игоревич | Способ обнаружения наличия, тяжести, риска и предрасположенности к рецидивам, а также лечения и реакции на лечение воспаления мочевыводящих путей и наборы для его описания |
BR102019017792A2 (pt) * | 2019-08-27 | 2021-11-16 | Fundação Oswaldo Cruz | Receptáculo proteico, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, e, uso do receptáculo |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
EP1307557A2 (en) * | 2000-08-02 | 2003-05-07 | The Johns Hopkins University | Endothelial cell expression patterns |
DE60128008T2 (de) | 2000-12-05 | 2008-01-10 | Wisconsin Alumni Research Foundation, Madison | Rezeptor für ein toxin aus bacillus anthracis |
EP1293569A3 (en) * | 2001-09-14 | 2004-03-31 | Research Association for Biotechnology | Full-length cDNAs |
WO2003033515A1 (en) * | 2001-10-15 | 2003-04-24 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of acne vulgaris |
US20030144193A1 (en) * | 2001-12-20 | 2003-07-31 | Rottman James B. | TANGO 197 and TANGO 216 compositions and methods |
US20030220287A1 (en) * | 2002-03-28 | 2003-11-27 | Phillips M. Ian | Antisense nucleic acids |
WO2004093804A2 (en) * | 2003-04-18 | 2004-11-04 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
WO2005108415A2 (en) * | 2004-04-30 | 2005-11-17 | Biogen Idec Ma Inc. | Membrane associated molecules |
-
2004
- 2004-10-28 GB GBGB0423974.5A patent/GB0423974D0/en not_active Ceased
-
2005
- 2005-10-28 UA UAA200705860A patent/UA93661C2/ru unknown
- 2005-10-28 BR BRPI0517362-0A patent/BRPI0517362A/pt not_active IP Right Cessation
- 2005-10-28 CA CA002584732A patent/CA2584732A1/en not_active Abandoned
- 2005-10-28 JP JP2007538515A patent/JP2008517616A/ja active Pending
- 2005-10-28 WO PCT/GB2005/004191 patent/WO2006046072A2/en active Application Filing
- 2005-10-28 EP EP05798912A patent/EP1812462A2/en not_active Withdrawn
- 2005-10-28 CN CN2005800441605A patent/CN101115767B/zh not_active Expired - Fee Related
- 2005-10-28 KR KR1020077010847A patent/KR20070085342A/ko not_active Application Discontinuation
- 2005-10-28 EA EA200700951A patent/EA013251B1/ru not_active IP Right Cessation
- 2005-10-28 US US11/718,183 patent/US8222371B2/en not_active Expired - Fee Related
- 2005-10-28 MX MX2007005054A patent/MX2007005054A/es active IP Right Grant
- 2005-10-28 AU AU2005298445A patent/AU2005298445B2/en not_active Ceased
-
2007
- 2007-04-23 NO NO20072076A patent/NO20072076L/no not_active Application Discontinuation
- 2007-04-23 IL IL182749A patent/IL182749A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2008517616A (ja) | 2008-05-29 |
EA200700951A1 (ru) | 2007-12-28 |
CN101115767A (zh) | 2008-01-30 |
UA93661C2 (ru) | 2011-03-10 |
US8222371B2 (en) | 2012-07-17 |
GB0423974D0 (en) | 2004-12-01 |
IL182749A (en) | 2012-09-24 |
KR20070085342A (ko) | 2007-08-27 |
CA2584732A1 (en) | 2006-05-04 |
NO20072076L (no) | 2007-07-25 |
BRPI0517362A (pt) | 2008-10-07 |
AU2005298445B2 (en) | 2011-08-25 |
US20090104197A1 (en) | 2009-04-23 |
AU2005298445A1 (en) | 2006-05-04 |
CN101115767B (zh) | 2011-06-22 |
EP1812462A2 (en) | 2007-08-01 |
WO2006046072A2 (en) | 2006-05-04 |
WO2006046072A3 (en) | 2007-01-25 |
IL182749A0 (en) | 2007-07-24 |
EA013251B1 (ru) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007005054A (es) | Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax. | |
IL169367A0 (en) | Defensin proteins | |
WO2006046073A3 (en) | C1q related protein | |
WO2008060814A3 (en) | ANTI-IL-13Rα1 ANTIBODIES AND THEIR USES THEREOF | |
WO2006043060A3 (en) | Mam domain containing protein | |
UA93658C2 (en) | Cell surface glycoprotein | |
WO2004096856A3 (en) | Secreted protein family | |
ATE512983T1 (de) | Rezeptor für das tgr3-like protein | |
WO2007049065A3 (en) | Vwfa, collagen and kunitz domain containing protein | |
WO2002070559A3 (en) | Nuclear hormone receptor ligand binding domains | |
WO2007068913A3 (en) | SRCR-B Domain Containing Proteins | |
WO2004009633A8 (en) | Serotonin receptor | |
WO2007049062A3 (en) | Vwfa-domain containing proteins | |
WO2004101618A3 (en) | Progestin-yol002c-cgi-45 receptor-related proteins | |
WO2004003010A3 (en) | Nuclear hormone receptor ligano-binding domain containing protein | |
GB0230006D0 (en) | Proteins | |
WO2005085285A3 (en) | Nuclear hormone receptors | |
WO2006051333A3 (en) | Leucine-rich repeat (lrr) motif containing proteins | |
GB0228441D0 (en) | Splice variant | |
WO2008001045A8 (en) | Members of the glycoside hydrolase family 31 family of proteins | |
WO2004005346A8 (en) | Human nuclear hormone receptor | |
WO2002062845A3 (en) | Adhesion molecules | |
WO2002070561A3 (en) | Nuclear hormone receptor ligand binding domain | |
WO2008017831A8 (en) | Secreted vit domain containing proteins | |
MXPA05012414A (es) | Proteina secretada similar a tnf. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |